Journal of the American Chemical Society p. 5931 - 5935 (1989)
Update date:2022-07-29
Topics:
Purvis, Michael B.
LeFevre, Joseph W.
Jones, Vickie L.
Kingston, David G. I.
Biot, Andre M.
Gossele, Francis
The formation of the dehydroproline residue of the antibiotic virginiamycin M1 occurs with equal facility from both (R)- and (S)-proline; the 3-pro-R proton of proline is lost stereospecifically in this process. cis-3-Hydroxyproline but not trans-3-hydroxyproline is incorporated into the antibiotic, although less efficiently than proline, and virginiamycin M2 is converted into virginiamycin M1.These results suggest that virginiamycin M1 is most probably formed by incorporation of (S)-proline into virginiamycin M2, which then undergoes hydroxylation withretention of configuration and elimination of water to yield virginiamycin M1.
View MoreShenzhen Sunrising Industry Co., ltd.
Contact:+86 755 86571158 / 86571159 / 86571160
Address:2108 ZHENYE INT. BUSINESS CENTER,NO.3101-90 QIANHAI RD, NANSHAN,SHENZHEN, CHINA
Contact:732.938.2777
Address:5012 Industrial Road Farmingdale, NJ 07727
Shandong Ailitong New Material Co.,Ltd
Contact:+86-536-3226266
Address:zhongjia village, putong town , qingzhou city,Shandong Province,China
Shanghai Yurui Biotechnology(Anyang) Pharmaceutical Co., Ltd
Contact:+86-0372-3662335 +86-0372-3661988
Address:hanling industrial park anyang
Jiangxi Huashi Pharmaceutical Co., Ltd
Contact:+86-795-4509628
Address:Ningbo Ave., Fengtian Industrial Park, Fengxin Country, Jiangxi, China.
Doi:10.1002/ejoc.200901113
(2010)Doi:10.1021/jo00067a009
(1993)Doi:10.1016/j.tetasy.2009.10.009
(2009)Doi:10.1039/b917549k
(2010)Doi:10.1021/ol100274e
(2010)Doi:10.1039/b919526b
(2010)